Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2018-05-15 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2018-05-15 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes amendments to the non-employee director compensation policy, election of directors, voting results from the annual meeting, and appointment of a new audit committee chairman. These topics relate to changes in board and management and shareholder voting results. The document is not a full annual report or earnings release, but rather a regulatory filing reporting corporate governance changes and voting outcomes. Given the detailed description of director compensation changes and appointments, the primary classification is Board/Management Information (MANG). The voting results section could suggest Declaration of Voting Results (DVA), but since the document also includes substantive management and board changes, MANG is more appropriate. The document length (8037 characters) and content confirm it is not a brief announcement or certification but a full 8-K report. Therefore, the best fit is MANG with high confidence.
2018-05-11 English
PRIMARY DOCUMENT
Director's Dealing
2018-05-10 English
PRIMARY DOCUMENT
Director's Dealing
2018-05-10 English
PRIMARY DOCUMENT
Director's Dealing
2018-05-10 English
PRIMARY DOCUMENT
Director's Dealing
2018-05-10 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.